Researchers at UCL have developed a method to reduce MRI scan times for dementia diagnosis by two-thirds, potentially doubling daily scan capacity and improving access to early care.
Professor Carlos Aguiar, Chair of the European Society of Cardiology (ESC) Communication Committee and spokesperson for Heart Failure, outlines the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.
Pascale V Guillot from University College London, Elizabeth Garrett Anderson Institute for Women’s Health, explains stem cell and gene therapy to treat osteogenesis imperfecta, but is this hype or hope?
This article describes how the collaboration inspires healthy behaviour change so critical in the prevention of type 2 diabetes and the management of all types of diabetes.
According to a Californian study, people over the age of 40 with type 1 diabetes are likely to experience severe COVID - leading to hospitalisation or death.
Captain Casey Barton Behravesh of the U.S. Public Health Service, and Director of the CDC One Health Office highlights the CDC’s efforts to nationally and internationally prevent zoonotic diseases.
With 7.5 million people living with HIV, how has climate change and COVID-19 affected the South African governments control over the AIDS crisis and which demographics have been hit the hardest?
Dr Lynn Woods, Professor in the Department of Doctoral Programs, School of Nursing, Azusa Pacific University, describes Latinx with dementia and in this respect, why culture matters.
Charles H. Vite, DVM, PhD from School of Veterinary Medicine at University of Pennsylvania, focuses on a fascinating aspect of neurological disorders concerning developing therapies for cats, dogs & patients.
Dr James E. Goldman, Professor of Pathology and Cell Biology at Columbia University, describes gaining more insight into disease mechanisms by comparing mouse genetic models with the human disease when it comes to Huntington’s Disease.
Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, explains why drug-candidate ABX464 has the potential to address the urgent need for new, safe short- and long-term effective drugs to treat Inflammatory Bowel Diseases.
Isabelle Ote and Valérie Barette, Project Leaders at Belgian immunotherapy expert Imcyse, discuss its next phase of growth, and how to apply ImotopeTM technology to the treatment of MS.
Chris Lynch, Deputy CEO at Alzheimer’s Disease International, sheds light on the WHO Global action plan on the public health response to dementia 2017-2025.
Professor Mogens Hørder, PPI expert, JPND’s management board member and representative of member state Denmark, discusses how Patient and Public Involvement (PPI) is at the heart of neurodegenerative disease research.
Professor Andrew Boulton, President & Professor Akhtar Hussain, President-Elect of the International Diabetes Federation, argue that while there has been a century of saving lives, more must be done to tackle diabetes.
